NCT04051281View on ClinicalTrials.gov

CMO Letter to Reduce Inappropriate Antibiotic Prescribing Winter 2019/2020

NACompletedINTERVENTIONAL
Enrollment

2,963

Participants

Timeline

Start Date

August 31, 2019

Primary Completion Date

August 30, 2020

Study Completion Date

August 30, 2020

Conditions
Prescribing, Off-Label
Interventions
BEHAVIORAL

Letter

Letters sent to GPs in relevant practices (prescribing data is by practice, so the practice is the unit of randomization)

Trial Locations (1)

SE1

Public Health England, London

All Listed Sponsors
lead

Public Health England

OTHER_GOV

NCT04051281 - CMO Letter to Reduce Inappropriate Antibiotic Prescribing Winter 2019/2020 | Biotech Hunter | Biotech Hunter